Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus

Molecular and Biochemical Parasitology

Volumn 95, Issue 2, 1998, Pages 193-201

  Blackhall, William J ^a   Liu, Hao Yuan ^a   Xu, Ming ^a   Prichard, Roger K ^a   Beech, Robin N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Drug resistance; Haemonchus contortus; Ivermectin; Moxidectin; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN; MOXIDECTIN;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAEMONCHUS CONTORTUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEMATODAL AGENTS; DNA, HELMINTH; DRUG RESISTANCE; GENE FREQUENCY; GENES, HELMINTH; HAEMONCHUS; HUMANS; IVERMECTIN; MACROLIDES; MICE; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SELECTION (GENETICS); SPECIES SPECIFICITY; VARIATION (GENETICS);

ANIMALIA; HAEMONCHUS CONTORTUS; PROTISTA;

EID: 0032531334     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(98)00087-5     Document Type: Article

References (44)

1. [1] Gibbs HC. Effects of parasites on animal and meat production. In: Gaafar SM, Howard WE, Marsh RE, editors. Parasites, Pests and Predators. New York: Elsevier, 1985:7-27.
2. [2] Prichard RK. Anthelmintic resistance in nematodes: Extent, recent understanding and future directions for control and research. Int J Parasitol 1990;20:515-23.
3. [3] Blouin MS, Dame JB, Tarrant CA, Courtney CH. Unusual population genetics of a parasitic nematode: mtDNA variation within and among populations. Evolution 1992;46:470-6.
4. [4] Beech RN, Prichard RK, Scott ME. Genetic variability of the β-tubulin genes in benzimidazole-susceptible and -resistant strains of Haemonchus contortus. Genetics 1994;138:103-10.
5. [5] Blouin MS, Yowell CA, Courtney CH, Dame JB. Host movement and the genetic structure of populations of parasitic nematodes. Genetics 1995;141:1007-14.
6. [6] Kwa MSG, Kooyman FSJ, Boersema JH, Roos MH. Effect of selection for benzimidazole resistance in Haemonchus contortus on β-tubulin isotype 1 and isotype 2 genes. Biochem Biophys Res Commun 1993;191:413-9.
7. [7] Kwa MSG, Veenstra JG, Roos MH. Molecular characterization of β-tubulin genes present in benzimidazole-resistant populations of Haemonchus contortus. Mol Biochem Parasitol 1993;60:133-44.
8. [8] Cully DF, Vassiliatis DK, Liu KK, Paress PS, Van Der Ploeg LHT, Schaeffer JM, Arena JP. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 1994;371:707-11.
9. [9] Arena JP, Liu KK, Paress PS, Frazier EG, Cully DF, Mrozik H, Schaeffer JM. The mechanism of action of avermectins in Caenorhabditis elegans: Correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity. J Parasitol 1995;81:286-94.
10. [10] Rohrer SP, Birzin ET, Eary CH, Schaeffer JM, Shoop WL. Ivermectin binding sites in sensitive and resistant Haemonchus contortus. J Parasitol 1994;80:493-7.
11. [11] Craig TM, Hatfield TA, Pankavich JA, Wang GT. Efficacy of moxidectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. Vet Parasitol 1992;41:329-33.
12. [12] Pankavich JA, Berger H, Simkins KL. Efficacy of moxidectin, nemadectin and ivermectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. Vet Rec 1992;130:241-3.
13. [13] Conder GA, Thompson DP, Johnson SS. Demonstration of co-resistance of Haemonchus contortus to ivermectin and moxidectin. Vet Rec 1993;132:651-2.
14. [14] Shoop WL, Haines HW, Michael BF, Eary CH. Mutual resistance to avermectins and milbemycins: Oral activity of ivermectin and moxidectin against ivermectin-resistant and susceptible nematodes. Vet Rec 1993;133:445-7.
15. [15] Van Wyk JA, Malan FS. Resistance of field strains of Haemonchus contortus to ivermectin, closantel, rafoxanide and the benzimidazoles in South Africa. Vet Rec 1988;123:226-8.
16. [16] Echevarria FAM, Trindade GNP. Anthelmintic resistance by Haemonchus contortus to ivermectin in Brazil: A preliminary report. Vet Rec 1989;124:147-8.
17. [17] Craig TM, Miller DK. Resistance by Haemonchus contortus to ivermectin in angora goats. Vet Rec 1990;126:580.
18. [18] Badger SB, McKenna PB. Resistance to ivermectin in a field strain of Ostertagia spp. in goats. New Zealand Vet J 1990;38:72-4.
19. [19] Jackson F, Coop RL, Jackson E, Scott EW, Russel AJF. Multiple anthelmintic resistant nematodes in goats. Vet Rec 1992;130:210.
20. [20] Le Jambre LF. Ivermectin-resistant Haemonchus contortus in Australia. Aust Vet J 1993;70:357.
21. [21] Pandey VS, Sivaraj S. Anthelmintic resistance in Haemonchus contortus from sheep in Malaysia. Vet Parasitol 1994;53:67-74.
22. [22] Mwamachi DM, Audho JO, Thorpe W, Baker RL. Evidence for multiple anthelmintic resitance in sheep and goats reared under the same management in coastal Kenya. Vet Parasitol 1995;60:303-13.
23. [23] Xu M, Molento M, Blackball WJ, Ribeiro P, Beech RN, Prichard RK. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol Biochem Parasitol 1998;91:327-35.
24. [24] Scotto KW, Biedler JL, Melera PW. Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 1986;232:751-5.
25. [25] Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet 1995;29:607-49.
26. [26] Schinkel AH, Smit JJ, Van Tellingen O, Beijnen JH, Wagenaar E, Van Deemter L, Mol CA, Van der Valk MA, Robanus-Maandag EC, Te Riele HP, Berns AJM, Borst P. Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.
27. [27] Didier A, Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anti-Cancer Drugs 1996;7:745-51.
28. [28] Pouliot J-F, L'Heureux F, Liu Z, Prichard RK, Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem Pharmacol 1997;53:17-25.
29. [29] Linke CA, The I, Van Groenigen M, Borst P. The P-glycoprotein gene family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences. J Mol Biol 1992;228:701-11.
30. [30] Broeks A, Gerrard B, Allikmets R, Dean M, Plasterk RHA. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 1996;15:6132-43.
31. [31] Broeks A, Janssen HW, Calafat J, Plasterk RHA. P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J 1995;14:1858-66.
32. [32] Wang GT, Berger K, Simkins K, Rock D. The rate of resistance development by H. contortus to endectocides. In: Proceedings of the XV International Conference of the World Association for the Advancement of Veterinary Parasitology. Japan: Yokohama, 1995;104.
33. [33] Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
34. [34] Chow LM, Wong AK, Ullman B, Wirth DF. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enrietii. Mol Biochem Parasitol 1993;60:195-208.
35. [35] Henderson DM, Sifri CD, Rodgers M, Wirth DF, Hendrickson N, Ullman B. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr 1 gene. Mol Cell Biol 1992;12:2855-65.
36. [36] Descoteaux S, Ayala P, Samuelson J, Orozco E. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene 1995;164:179-84.
37. [37] Foote SJ, Thompson JK, Cowman AF, Kemp DJ. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 1989;57:921-30.
38. [38] Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989;244:1184-6.
39. [39] Wellems TE, Pantan LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 1990;345:253-5.
40. [40] Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF. Selection for high-level chlororquine resistance results in deamplification of the pfmdr 1 gene and increases sensitivity to mefloquine in Plasmodium falciparum. EMBO J 1992;11:3067-75.
41. [41] Lanning CL, Fine RL, Sachs CW, Rao US, Corcoran JJ, Abou-Donia MB. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein. J Tox Environ Health 1996;47:395-407.
42. [42] Murray CL, Quaglia M, Arnason JT, Morris CE. A putative nicotine pump at the metabolic blood-brain barrier of the tobacco hornworm. J Neurobiol 1994;25:23-4.
43. [43] Blackball WJ, Pouliot J-F, Prichard RK, Beech RN. Haemonchus contortus: Selection at a glutamate-gated chloride channel subunit gene in ivermectin-and moxidectin-selected strains. Exp Parasitol 1998 (in press).
44. [44] Dudler R, Hertig C. Structure of an mdr-like gene from Arabidopsis thaliana. Evolutionary implications. J Biol Chem 1992;267:5882-8.